Delivery Order SPE2DB20D1051-SPE2DB24FD6YZ

Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RISPERIDONE 4 MG TABLET 500S for $3,384.23. The delivery order has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies in...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,501,293 units of the 2 mg Risperidone tablet in 500-count bottles. The potential value of this award is $3,026.01, with a completion date of February 1, 2024. This delivery order is not associated with any set-aside program. Amerisourcebergen Drug Corp is the prime contractor and has a history of providing...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4 mg risperidone tablets. The $3,592.63 contract has a performance period through March 13, 2024 and does not include any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 500 tablets of Risperidone 0.25 mg. The contract has a potential value of $5,046.84 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award, valued at $3,362.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of 4,564,222,796 units of Risperidone 2 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation, is the prime contractor on this award. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,558.00 fixed-price contract is for the delivery of 4,565,584,617 risperidone 3 mg tablets. This order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $2,118.28 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 500 tablets of the 3 mg dosage of the drug risperidone. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 4th through August 7th, 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity...
The U.S. Department of Defense's Medical Supply Chain agency awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,558,617 units of 0.25 mg Risperidone tablets, a prescription medication. The fixed-price contract, valued at $30,000.17, has a completion date of September 28, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,127.06, is for the delivery of 4,566,258 units of Risperidone 2 mg tablets. It is a firm-fixed price contract with a completion date of October 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a firm fixed price delivery order for Risperidone 2 mg tablets to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $2,005.50 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. The award is associated with a larger indefinite delivery contract...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD6YZ
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,644.11 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,596,227 units of RISPERIDONE 2 MG TABLET with a completion date of February 9, 2024. This delivery order is issued under a previously awarded indefinite delivery contract (IDC) with DLA, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC does not have any set-aside designations and has a potential value of $999,999,999.00 with a performance period through December 31, 2025.

Generated 5/9/24, 10:20 AM